|
|
Eric A. Jaffe, Leon W. Hoyer, Ralph L. Nachman
J Clin Invest. 1973;
52(11):2757
doi:10.1172/JCI107471
Abstract |
Full text
| PDF

A
ntihemophilic factor (AHF, Factor VIII) antigen has been demonstrated in cultured human endothelial cells by immunofluorescence studies using monospecific rabbit antibody to human AHF. Control studies with cultured human smooth muscle cells and human fibroblasts were negative. By radioimmunoassay it was demonstrated that cultured human endothelial cells contain AHF antigen which is released into the culture medium. Cultured smooth muscle cells and fibroblasts did not have this property. Cultured endothelial cells incorporated radioactive amino acids into high molecular weight, AHF antigen-rich protein fractions prepared from the culture media, 7% of the radioactive amino acid counts incorporated into this material were precipitated by globulin prepared from rabbit anti-AHF whereas normal rabbit globulin precipitated only 1.5% of the counts. Although cultured endothelial cells actively synthesize AHF antigen, AHF procoagulant activity was not detected in the culture medium. Studies seeking a basis for the lack of procoagulant activity have not clarified this deficiency, but they have established that exogenous AHF procoagulant activity is not inactivated by the tissue culture system.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(443)
| Title and authors |
Publication |
Year |
Endothelium: from cellophane to orchestral maestro
Ralph L. Nachman
|
J. Clin. Invest.
|
2012 |
Von Willebrand Disease
Sandra L. Haberichter
|
Von Willebrand Disease
|
2011 |
Comprehensive Physiology
Russell Ross, Beverly Kariya
|
Comprehensive Physiology
|
2011 |
Native multimer analysis of plasma and platelet von Willebrand factor compared to denaturing separation: Implication for the interpretation of satellite bands
Kurt Hohenstein, Andrea Griesmacher, Günter Weigel, Georg Golderer, Helmut Werner Ott
|
Electrophoresis
|
2011 |
Endothelial cell surface vimentin binding peptide induces angiogenesis under hypoxic/ischemic conditions
Leticia Glaser-Gabay, Annat Raiter, Alexander Battler, Britta Hardy
|
Microvascular Research
|
2011 |
Engineered Mammalian Vector to Express EGFP-Tagged Proteins as Biomarkers
Geraldo Santana Magalhães, Juliana Branco Novo, Patricia Bianca Clissa, Maisa Splendore Casa, Diego Butera, Ana Maria Moura da Silva
|
Mol Biotechnol
|
2011 |
Expression of dysadherin in the human male reproductive tract and in spermatozoa
Nieves María Gabrielli, María Florencia Veiga, María Laura Matos, Silvina Quintana, Héctor Chemes, Gustavo Blanco, Mónica Hebe Vazquez-Levin
|
Fertility and Sterility
|
2011 |
VWF and ADAMTS13 behavior in estradiol-treated HUVEC
Yanina Powazniak, Ana Catalina Kempfer, Julio César Calderazzo Pereyra, Juvenal Paiva Palomino, Maria Angela Lazzari
|
European Journal of Haematology
|
2011 |
Platelets as delivery systems for disease treatments
Qizhen Shi, Robert R. Montgomery
|
Advanced Drug Delivery Reviews
|
2010 |
Targeting FVIII expression to endothelial cells regenerates a releasable pool of FVIII and restores hemostasis in a mouse model of hemophilia A
Q. Shi, S. A. Fahs, E. L. Kuether, B. C. Cooley, H. Weiler, R. R. Montgomery
|
Blood
|
2010 |
|